31 results
Summary of characteristics of Antianginal Drugs

DRUG CLASS, ADVERSE EFFECTS 
 AND DRUG 
INTERACTIONS 

#Antianginal #Medications #Cardiology
of Antianginal Drugs ... EFFECTS AND ... Medications #Cardiology #Pharmacology ... #Management #Therapy ... #Table #Overview
Summary table of mechanism of action, side effect and contraindications of commonly used drugs for tuberculosis.
Summary table of ... of action, side effect ... commonly used drugs ... #pharmacology #medications ... #table #management
Summary table of the mechanism of action, side effect and contraindications of commonly used non-steroidal anti-inflammatory
Summary table of ... of action, side effect ... anti-inflammatory drugs ... #NSAIDS #management ... #pharmacology #
Summary table of mechanism of action, side effect and contraindications of commonly used diabetic drugs. 

#pharmacology
Summary table of ... of action, side effect ... used diabetic drugs ... #pharmacology #dm2 ... medications #overview #management
Doses of Antituberculosis Drugs for Adults and Children - IDSA
First-line drugs:
 • Isoniazid
 • Rifampin
 •
and Children - IDSA ... First-line drugs ... #Medications #management ... #pharmacology # ... Table
Summary table of the mechanism of action, side effect and contraindications of commonly used anti-coagulation drugs.
Summary table of ... of action, side effect ... anti-coagulation drugs ... anticoagulation #pharmacology ... #management #drugs
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
kidney), which causes ... glucose in the urine ... include side effects ... SGLT2 #Inhibitors #Pharmacology ... DM2 #Diabetes #Endocrinology
Shock and Vasoactive Drugs 
1) Determine type and etiology of shock
 • Distributive: Sepsis, Anaphylaxis, Neurogenic
Disease, Mechanical Defect ... pharmacology ... #pharmacology # ... inopressors #diagnosis #management ... #comparison #table
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
4 Inhibitors - Pharmacology ... failure Common Side Effects ... not definitively cause ... /effect) • Saxagliptin ... DM2 #diabetes #endocrinology
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
hypoglycemia risk and effect ... #pharmacology #pharmacotherapy ... #table #comparison ... #management #medications ... #diabetes #endocrinology